{"id":"https://openalex.org/W2140181964","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1275","title":"Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H)","display_name":"Heterogeneous CD52 Expression among Hematologic Neoplasms: Implications for the Use of Alemtuzumab (CAMPATH-1H)","publication_year":2006,"publication_date":"2006-12-01","ids":{"openalex":"https://openalex.org/W2140181964","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1275","mag":"2140181964","pmid":"https://pubmed.ncbi.nlm.nih.gov/17145843"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-06-1275","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1275","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-1275","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J. Rodig","raw_affiliation_strings":["1Department of Pathology, Brigham and Women's Hospital,","Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115 , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pathology, Brigham and Women's Hospital,","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115 , USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002103749","display_name":"Jeremy S. Abramson","orcid":"https://orcid.org/0000-0001-8467-9257","observed_orcids":["https://orcid.org/0000-0001-8467-9257"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy S. Abramson","raw_affiliation_strings":["2Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112148042","display_name":"Geraldine S. Pinkus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geraldine S. Pinkus","raw_affiliation_strings":["1Department of Pathology, Brigham and Women's Hospital,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pathology, Brigham and Women's Hospital,","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081299017","display_name":"Steven Peter Treon","orcid":"https://orcid.org/0000-0001-6393-6154","observed_orcids":["https://orcid.org/0000-0001-6393-6154"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven P. Treon","raw_affiliation_strings":["2Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027464923","display_name":"David M. Dorfman","orcid":"https://orcid.org/0000-0002-6244-8535","observed_orcids":["https://orcid.org/0000-0002-6244-8535"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Dorfman","raw_affiliation_strings":["1Department of Pathology, Brigham and Women's Hospital,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pathology, Brigham and Women's Hospital,","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112238070","display_name":"Henry Y. Dong","orcid":"https://orcid.org/0009-0008-7671-7100","observed_orcids":["https://orcid.org/0009-0008-7671-7100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Y. Dong","raw_affiliation_strings":["3Genzyme Genetics, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Genzyme Genetics, New York, New York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021363179","display_name":"Margaret Ann Shipp","orcid":"https://orcid.org/0000-0002-3949-6897","observed_orcids":["https://orcid.org/0000-0002-3949-6897"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret A. Shipp","raw_affiliation_strings":["2Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005876566","display_name":"Jeffery Lorne Kutok","orcid":"https://orcid.org/0009-0009-9931-3106","observed_orcids":["https://orcid.org/0009-0009-9931-3106"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffery L. Kutok","raw_affiliation_strings":["1Department of Pathology, Brigham and Women's Hospital,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pathology, Brigham and Women's Hospital,","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.3289,"has_fulltext":false,"cited_by_count":135,"citation_normalized_percentile":{"value":0.97575896,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"12","issue":"23","first_page":"7174","last_page":"7179"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.2632000148296356,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd52","display_name":"CD52","score":0.9729999899864197},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/campath-1h","display_name":"Campath-1H","score":0.9350000023841858},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9200000166893005},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8209999799728394},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8320000171661377},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.8220000267028809},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.7699999809265137},{"id":"https://openalex.org/keywords/hairy-cell-leukemia","display_name":"hairy cell leukemia","score":0.9190000295639038},{"id":"https://openalex.org/keywords/malt-lymphoma","display_name":"MALT lymphoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/target-validation","display_name":"target validation","score":0.5049999952316284},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2778384904","wikidata":"https://www.wikidata.org/wiki/Q21108353","display_name":"CD52","level":4,"score":0.9788507223129272},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.8313621878623962},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7481850385665894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6571092009544373},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.643791913986206},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5399764180183411},{"id":"https://openalex.org/C2780483514","wikidata":"https://www.wikidata.org/wiki/Q201299","display_name":"Hairy cell leukemia","level":3,"score":0.43979576230049133},{"id":"https://openalex.org/C2776995267","wikidata":"https://www.wikidata.org/wiki/Q4165484","display_name":"Lymphoproliferative disorders","level":3,"score":0.4249134063720703},{"id":"https://openalex.org/C2777478502","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic lymphoma","level":4,"score":0.4168437123298645},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39149659872055054},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.367798775434494},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33436399698257446},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.25823867321014404},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18694564700126648},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.07301434874534607}],"mesh":[{"descriptor_ui":"D000074301","descriptor_name":"CD52 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074323","descriptor_name":"Alemtuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000912","descriptor_name":"Antibodies, Neoplasm","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008232","descriptor_name":"Lymphoproliferative Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008232","descriptor_name":"Lymphoproliferative Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008232","descriptor_name":"Lymphoproliferative Disorders","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-06-1275","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1275","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-1275","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:17145843","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17145843","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W417406195","https://openalex.org/W1833241997","https://openalex.org/W1908969923","https://openalex.org/W1923936497","https://openalex.org/W1954038871","https://openalex.org/W1989053318","https://openalex.org/W1989091670","https://openalex.org/W2015421929","https://openalex.org/W2016373265","https://openalex.org/W2029032380","https://openalex.org/W2029854218","https://openalex.org/W2054581370","https://openalex.org/W2066104625","https://openalex.org/W2072813895","https://openalex.org/W2076085163","https://openalex.org/W2089114693","https://openalex.org/W2092107377","https://openalex.org/W2101623539","https://openalex.org/W2132589242","https://openalex.org/W2143749371","https://openalex.org/W2157626001","https://openalex.org/W2162359545","https://openalex.org/W2162613257","https://openalex.org/W2168799171","https://openalex.org/W4234971900"],"related_works":["https://openalex.org/W2557476718","https://openalex.org/W2052005705","https://openalex.org/W2611925666","https://openalex.org/W1966339351","https://openalex.org/W2090481009","https://openalex.org/W7100332989","https://openalex.org/W2532057534","https://openalex.org/W2463322501","https://openalex.org/W27425312","https://openalex.org/W2559158582"],"abstract_inverted_index":{"PURPOSE:":[0],"CD52":[1,24,63,88,157,238,249],"is":[2,21,26,153],"a":[3,59,66,259],"GPI-linked":[4],"glycoprotein":[5],"expressed":[6],"by":[7],"B":[8,112,142,162,172],"cells,":[9,11],"T":[10,190,203,214],"monocytes,":[12],"and":[13,25,28,126,175,212,232],"macrophages.":[14],"The":[15,44,107],"humanized":[16],"monoclonal":[17],"antibody":[18],"alemtuzumab":[19],"(CAMPATH-1H)":[20],"specific":[22],"for":[23,33,84,195,237],"Food":[27],"Drug":[29],"Administration":[30],"-":[31],"approved":[32],"the":[34,49,85,138,184,189,196,221,245,268],"treatment":[35,50],"of":[36,46,51,62,69,87,110,140,167,169,186,188,201,224,226,248,271],"relapsed":[37],"or":[38,104],"refractory":[39],"chronic":[40],"lymphocytic":[41,117],"leukemia":[42],"(CLL).":[43],"utility":[45],"CAMPATH":[47,272],"in":[48,156],"other":[52,251],"hematologic":[53,82,252],"neoplasms":[54,83,187],"has":[55,73],"been":[56,75],"explored;":[57],"however,":[58],"comprehensive":[60],"survey":[61],"expression":[64,158,247],"among":[65,159,250],"broad":[67],"spectrum":[68],"WHO-defined":[70],"tumor":[71],"types":[72],"not":[74,217],"completed.":[76],"EXPERIMENTAL":[77],"DESIGN:":[78],"We":[79],"evaluated":[80],"294":[81],"presence":[86],"using":[89],"standard":[90],"immunohistochemical":[91],"techniques":[92],"on":[93,258],"paraffin-embedded":[94],"biopsy":[95],"specimens":[96],"fixed":[97],"with":[98,165,243],"formalin,":[99],"B-Plus,":[100],"Zenker's":[101],"acetic":[102],"acid,":[103],"B5-formalin.":[105],"RESULTS:":[106],"vast":[108,222],"majority":[109,139,185,223],"low-grade":[111],"cell":[113,124,143,163,173,191,204,210,215],"lymphoproliferative":[114],"disorders":[115],"(CLL/small":[116],"leukemia,":[118,125,229],"follicular":[119],"lymphoma,":[120,122,211,216,231],"lymphoplasmacytic":[121],"hairy":[123],"mucosa-associated":[127],"lymphoid":[128],"tissue":[129],"lymphomas)":[130],"express":[131,147],"CD52.":[132,181],"In":[133,150,182,241],"addition,":[134,183],"we":[135],"found":[136],"that":[137,255],"precursor":[141,202],"acute":[144,205,227],"lymphoblastic":[145,206],"leukemia/lymphomas":[146],"this":[148],"antigen.":[149],"contrast,":[151],"there":[152],"surprising":[154],"heterogeneity":[155],"more":[160],"aggressive":[161],"lymphomas,":[164],"25%":[166],"cases":[168,200,225],"diffuse":[170],"large":[171,209],"lymphoma":[174,177],"Burkitt":[176],"demonstrating":[178],"no":[179],"detectable":[180],"lineage":[192],"are":[193,235],"negative":[194,236],"antigen,":[197],"including":[198],"most":[199],"leukemia/lymphoma,":[207],"anaplastic":[208],"peripheral":[213],"otherwise":[218],"specified.":[219],"Finally,":[220],"myeloid":[228],"Hodgkin":[230],"multiple":[233],"myeloma":[234],"expression.":[239],"CONCLUSION:":[240],"contrast":[242],"CLL,":[244],"variable":[246],"malignancies":[253],"suggests":[254],"target":[256],"validation":[257],"case-by-case":[260],"basis":[261],"will":[262],"likely":[263],"be":[264],"necessary":[265],"to":[266],"guide":[267],"rational":[269],"analysis":[270],"therapy.":[273]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}